Adalimumab (UNSPSC 51142145)

Median $167.20IQR $91.33–$364.84Converted — derived

78 of 80 records carry a dollar figure. Publisher’s own median CLP 156,742 · IQR CLP 82,900–CLP 339,662.

80 competitive-award records from 63 contracting processes · tax excluded · median from 78 of 80 records · 2 removed as outliers

Median $11.18IQR $6.88–$126.63Converted — derived

9 of 9 records carry a dollar figure. Publisher’s own median CLP 8,840 · IQR CLP 6,616–CLP 100,168.

9 competitive-award records from 6 contracting processes · tax excluded · median from 9 of 9 records

Median $177.50IQR $93.02–$264.39Converted — derived

9 of 9 records carry a dollar figure. Publisher’s own median CLP 168,709 · IQR CLP 88,001–CLP 246,032.

9 competitive-award records from 7 contracting processes · tax excluded · median from 9 of 9 records

1 eligible record. A median is not computed from fewer than 5, so none is shown.

1 eligible record. A median is not computed from fewer than 5, so none is shown.

4 eligible records. A median is not computed from fewer than 5, so none is shown.

3 eligible records. A median is not computed from fewer than 5, so none is shown.

4 records exist for this currency and tax basis, and none are eligible for a benchmark: 4 Line total, not a unit price — no unit given and quantity 1, so the per-unit basis was never established; shown but not averaged.